Suppr超能文献

碳酸酐酶抑制剂;氟化苯基磺胺对肿瘤相关同工酶IX和XII的抑制作用表现出强抑制活性和选择性,优于对胞质同工酶I和II的抑制作用。

Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II.

作者信息

Winum Jean-Yves, Innocenti Alessio, Vullo Daniela, Montero Jean-Louis, Supuran Claudiu T

机构信息

Institut des Biomolécules Max Mousseron (IBMM), UMR 5247 CNRS-UM1-UM2, Bâtiment de Recherche Max Mousseron, Ecole Nationale Supérieure de Chimie de Montpellier, 8 rue de l'Ecole Normale, Montpellier Cedex, France.

出版信息

Bioorg Med Chem Lett. 2009 Sep 1;19(17):5082-5. doi: 10.1016/j.bmcl.2009.07.056. Epub 2009 Jul 23.

Abstract

A series of fluorinated-phenylsulfamates have been prepared by sulfamoylation of the corresponding phenols and the inhibition of four physiologically relevant carbonic anhydrase (CA, EC 4.2.1.1) isozymes, the cytosolic CA I and II (off-targets), and the transmembrane, tumor-associated CA IX and XII is investigated. Unlike the lead molecule (phenylsulfamate), a very potent CA I and II inhibitor and a modest CA IX/XII inhibitor, the fluorinated sulfamates were stronger inhibitors of CA IX (K(I)s of 2.8-47 nM) and CA XII (K(I)s of 1.9-35 nM) than of CA I (K(I)s of 53-415 nM) and CA II (K(I)s of 20-113 nM). Some of these compounds were selective CA IX over CA II inhibitors, with selectivity ratios in the range of 11.4-12.1, making them interesting candidates for targeting hypoxic tumors overexpressing CA IX and/or XII.

摘要

通过相应酚类的氨磺酰化反应制备了一系列氟化苯磺酸酯,并研究了它们对四种生理相关碳酸酐酶(CA,EC 4.2.1.1)同工酶的抑制作用,即胞质CA I和II(脱靶)以及跨膜的、肿瘤相关的CA IX和XII。与先导分子(苯磺酸酯)不同,先导分子是一种非常有效的CA I和II抑制剂以及适度的CA IX/XII抑制剂,氟化苯磺酸酯对CA IX(抑制常数K(I)为2.8 - 47 nM)和CA XII(抑制常数K(I)为1.9 - 35 nM)的抑制作用比对CA I(抑制常数K(I)为53 - 415 nM)和CA II(抑制常数K(I)为20 - 113 nM)更强。其中一些化合物是CA IX相对于CA II的选择性抑制剂,选择性比率在11.4 - 12.1范围内,这使得它们成为靶向过表达CA IX和/或XII的缺氧肿瘤的有趣候选物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验